Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0406 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Onchocerca volvulus | 0.0015 | 0.0406 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Schistosoma mansoni | discoidin domain receptor | 0.0015 | 0.0406 | 0.0297 |
Trypanosoma cruzi | multicopper oxidase, putative | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0406 | 1 |
Mycobacterium ulcerans | oxidase | 0.0014 | 0.0368 | 0.5 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0015 | 0.0406 | 1 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0015 | 0.0406 | 0.0297 |
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0015 | 0.0406 | 0.5 |
Schistosoma mansoni | discoidin domain receptor | 0.0015 | 0.0406 | 0.0297 |
Plasmodium vivax | LCCL domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0011 | 0 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Schistosoma mansoni | dock | 0.0092 | 1 | 1 |
Onchocerca volvulus | 0.0015 | 0.0406 | 1 | |
Echinococcus multilocularis | nuclear receptor 2C2 associated protein | 0.0015 | 0.0406 | 0.0297 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0011 | 0 | 0.5 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0015 | 0.0406 | 0.0297 |
Echinococcus granulosus | discoidin domain receptor | 0.0015 | 0.0406 | 0.0297 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Echinococcus multilocularis | Coagulation factor 5 8 type, C terminal | 0.0092 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0406 | 0.0297 |
Trypanosoma brucei | multicopper oxidase, putative | 0.0011 | 0 | 0.5 |
Trypanosoma cruzi | multicopper oxidase, putative | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0015 | 0.0406 | 0.5 |
Echinococcus multilocularis | dedicator of cytokinesis protein | 0.0078 | 0.8196 | 0.8175 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0015 | 0.0406 | 1 |
Echinococcus multilocularis | discoidin domain receptor | 0.0015 | 0.0406 | 0.0297 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0015 | 0.0406 | 0.0297 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0015 | 0.0406 | 0.5 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0015 | 0.0406 | 0.0297 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Plasmodium vivax | LCCL domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0015 | 0.0406 | 0.0297 |
Schistosoma mansoni | septate junction protein | 0.0015 | 0.0406 | 0.0297 |
Schistosoma mansoni | btb and poz domain-containing protein | 0.0015 | 0.0406 | 0.0297 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Toxoplasma gondii | PA14 domain-containing protein | 0.0015 | 0.0406 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0406 | 1 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0015 | 0.0406 | 0.5 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0015 | 0.0406 | 0.0297 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0.0406 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.